Last reviewed · How we verify
PO Acetaminophen
PO Acetaminophen, marketed by Corewell Health West, is a well-established over-the-counter pain reliever and fever reducer. The key composition patent is set to expire in 2028, providing a period of market exclusivity and potential revenue stability. The primary risk lies in the competitive landscape, where multiple generic and branded alternatives are already available.
At a glance
| Generic name | PO Acetaminophen |
|---|---|
| Also known as | Tylenol, tylenol, Acetaminophen Elixir |
| Sponsor | Corewell Health West |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters (PHASE2)
- A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma (PHASE2)
- Paracetamol With or Without Ketoprofen in the Management of Pain for Patients Receiving Brachytherapy (KETOCOL-1304) (PHASE2)
- Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma (PHASE2)
- Daratumumab in STK11 Mutated NSCLC (PHASE2)
- E7 TCR T Cells for Human Papillomavirus-Associated Cancers (PHASE1, PHASE2)
- High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer (PHASE3)
- A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PO Acetaminophen CI brief — competitive landscape report
- PO Acetaminophen updates RSS · CI watch RSS
- Corewell Health West portfolio CI